Furthermore, treatment with Abemaciclib markedly mitigated YAP1 protein levels and exhibited a substantial tumor-suppressive effect in HCC cells reconstituted with DUB3 WT. This evidence concerns the gene USP17L2 and hepatocellular carcinoma.